Latest Uk Market News

Page 4 of 14
PEXA Group delivered a 7.3% rise in Australian property transaction volumes in 3Q26 and saw steady UK remortgage growth despite macroeconomic uncertainty. The company reaffirmed its FY26 guidance, aiming for NPAT at the top of its $15m-$25m range.
Sophie Babbage
Sophie Babbage
4 May 2026
4DMedical has made significant strides in commercial adoption of its CT:VQ™ lung imaging technology, securing top US hospital contracts, regulatory approvals in Europe and the UK, and a major pharmaceutical partnership, all backed by strong capital raises and inclusion in the S&P/ASX 200.
Ada Torres
Ada Torres
30 Apr 2026
Microba Life Sciences reported a 99% year-on-year surge in core testing revenue for Q3 FY26, propelled by strong test volume growth and new clinic contracts in Australia and the UK. The company is advancing a major product release and negotiating a significant corporate transaction to bolster its financial position.
Ada Torres
Ada Torres
30 Apr 2026
Alcidion Group delivered positive cashflow and strong new sales in Q3 FY26, with contract expansions in the UK and Australia. The company remains on track for a significant Electronic Patient Record contract signing in May.
Victor Sage
Victor Sage
29 Apr 2026
HITIQ Limited's March quarter saw a remarkable 223% jump in sales to $294k, driven by the nationwide rollout of its PROTEQT™ concussion management system and initial international sales. The company bolstered its governance and advisory ranks while managing funding to support its commercial push.
Victor Sage
Victor Sage
27 Apr 2026
4DMedical lands a contract with pharma giant GSK, gains UKCA certification for its CT:VQ™ lung imaging technology, and joins the S&P/ASX 200, marking a significant step in its global expansion.
Ada Torres
Ada Torres
20 Apr 2026
Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.
Ada Torres
Ada Torres
17 Apr 2026
Love Group Global Ltd reported a 15% decline in quarterly customer cash receipts to $884k in Q3 FY26, driven by a sharp drop in Hong Kong. Despite this, the company maintained positive net operating cash flow and is pursuing growth in US and UK markets.
Victor Sage
Victor Sage
15 Apr 2026
PEXA Group has successfully onboarded NatWest onto its UK digital property platform for remortgage transactions, marking a significant milestone in modernising the UK property market.
Sophie Babbage
Sophie Babbage
25 Mar 2026
Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.
Ada Torres
Ada Torres
10 Mar 2026
Halo Technologies Holdings Ltd posted a $17.4 million loss for 2025, widening from $14.5 million the previous year, as revenue fell 16%. The company completed a $3.9 million rights issue and announced a strategic pivot in its UK operations.
Claire Turing
Claire Turing
27 Feb 2026
PEXA Group Limited reported a 10% revenue increase and a 19% rise in EBITDA for the half-year ended December 2025, while announcing its strategic exit from the Digital Solutions segment with a significant loss.
Sophie Babbage
Sophie Babbage
27 Feb 2026

Browse the archive

Full archive